Bristol Myers Squibb Co. (BMY)
59.86
-0.07
(-0.12%)
USD |
NYSE |
Feb 12, 16:00
59.76
-0.10
(-0.17%)
After-Hours: 20:00
Bristol Myers Squibb Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen, Inc. | -693.00M |
| Gilead Sciences, Inc. | -1.835B |
| Johnson & Johnson | -- |
| Regeneron Pharmaceuticals, Inc. | 220.30M |
| Janux Therapeutics, Inc. | 8.306M |
Cash from Investing (Quarterly) Related Metrics
| Free Cash Flow | 15.30B |
| Free Cash Flow Per Share (Quarterly) | 2.938 |
| Free Cash Flow to Equity (Quarterly) | 5.879B |
| Free Cash Flow to Firm (Quarterly) | 6.329B |
| Free Cash Flow Yield | 12.53% |